Cargando…
Hematologic modifications in natalizumab-treated multiple sclerosis patients: An 18-month longitudinal study
OBJECTIVE: To monitor the hematologic modifications in the peripheral blood of patients with relapsing-remitting multiple sclerosis treated with natalizumab. METHODS: The cohort included 44 patients with relapsing-remitting multiple sclerosis treated monthly with natalizumab for 18 months. Periphera...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476051/ https://www.ncbi.nlm.nih.gov/pubmed/26140281 http://dx.doi.org/10.1212/NXI.0000000000000123 |